Abstract
In patients with HIV infection who had previously received zidovudine, 150 mg of lamivudine plus zidovudine resulted in greater immunologic evidence of benefit than did 0.75 mg of zalcitabine plus zidovudine and was better tolerated than 300 mg of lamivudine plus zidovudine.
Keywords
ZalcitabineZidovudineLamivudineMedicineInternal medicineAdverse effectGastroenterologyChemotherapySidaVirologyViral diseaseVirus
Affiliated Institutions
Related Publications
Immunologic NO Synthase: Elevation in Severe AIDS Dementia and Induction by HIV-1 gp41
Indirect mechanisms are implicated in the pathogenesis of the dementia associated with human immunodeficiency virus-type 1 (HIV-1) infection. Proinflammatory molecules such as t...
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
In patients with previously untreated metastatic, squamous NSCLC, the addition of pembrolizumab to chemotherapy with carboplatin plus paclitaxel or nab-paclitaxel resulted in si...
Update on prevention, diagnosis, and treatment of chronic hepatitis B
Potential conflict of interest: Dr. Hwang received grants from Merck and Gilead. Dr. Chang advises Arbutus. Dr. Lok received grants from Gilead and Bristol‐Myers Squibb. Dr. Jon...
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
In patients with advanced NSCLC and PD-L1 expression on at least 50% of tumor cells, pembrolizumab was associated with significantly longer progression-free and overall survival...
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
BACKGROUND Nivolumab plus ipilimumab or nivolumab alone resulted in longer progression-free and overall survival than ipilimumab alone in a trial involving patients with advance...
Publication Info
- Year
- 1996
- Type
- article
- Volume
- 125
- Issue
- 3
- Pages
- 161-172
- Citations
- 110
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
110
OpenAlex
Cite This
John Bartlett
(1996).
Lamivudine Plus Zidovudine Compared with Zalcitabine Plus Zidovudine in Patients with HIV Infection.
Annals of Internal Medicine
, 125
(3)
, 161-172.
https://doi.org/10.7326/0003-4819-125-3-199608010-00001
Identifiers
- DOI
- 10.7326/0003-4819-125-3-199608010-00001